Previous Article | Next Article 
Journal of Virology, January 2001, p. 115-124, Vol. 75, No. 1
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.1.115-124.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Alteration of Zinc-Binding Residues of Simian
Immunodeficiency Virus p8NC Results in Subtle
Differences in Gag Processing and Virion Maturation Associated with
Degradative Loss of Mutant NC
Jason L.
Yovandich,
Elena N.
Chertova,
Brad P.
Kane,
Tracy D.
Gagliardi,
Julian W.
Bess Jr.,
Raymond C.
Sowder II,
Louis E.
Henderson, and
Robert J.
Gorelick*
AIDS Vaccine Program, SAIC-Frederick,
National Cancer Institute, Frederick, Maryland 21702-1201
Received 10 May 2000/Accepted 8 October 2000
 |
ABSTRACT |
In all retroviruses analyzed to date (except for the
spumaretroviruses), the Zn2+-coordinating residues of
nucleocapsid (NC) perform or assist in crucial reactions necessary to
complete the retrovirus life cycle. Six replication-defective mutations
have been engineered in the two NC Zn2+ fingers (ZFs) of
simian immunodeficiency virus [SIV(Mne)] that change or delete
specific Zn2+-interacting Cys residues and were studied by
using electron microscopy, reversed-phase high-performance liquid
chromatography, immunoblotting, and RNA quantification. We focused on
phenotypes of produced particles, specifically morphology, Gag
polyprotein processing, and genomic RNA packaging. Phenotypes were
similar among viruses containing a point or deletion mutation involving
the same ZF. Mutations in the proximal ZF (ZF1) resulted in near-normal
Gag processing and full-length genomic RNA incorporation and were most
similar to wild-type (WT) virions with electron-dense, conical cores. Mutation of the distal ZF, as well as point mutations in both ZFs,
resulted in more unprocessed Gag proteins than a deletion or point
mutation in ZF1, with an approximate 30% reduction in levels of
full-length genomic RNA in virions. These mutant virions contained
condensed cores; however, the cores typically appeared less electron
dense and more rod shaped than WT virions. Surprisingly, deletion of
both ZFs, including the basic linker region between the ZFs, resulted
in the most efficient Gag processing. However, genomic RNA packaging
was ~10% of WT levels, and those particles produced were highly
abnormal with respect to size and core morphology. Surprisingly, all NC
mutations analyzed demonstrated a significant loss of processed NC in
virus particles, suggesting that Zn2+-coordinated NC is
protected from excessive proteolytic cleavage. Together, these results
indicate that Zn2+ coordination is important for correct
Gag precursor processing and NC protein stability. Additionally, SIV
particle morphology appears to be the result of proper and complete Gag
processing and relies less on full-length genomic RNA incorporation, as
dictated by the Zn2+ coordination in the ZFs of the NC protein.
 |
INTRODUCTION |
Retroviral nucleocapsid (NC)
proteins are typically small basic proteins containing one or two
conserved 14-residue peptide segments
(-C-[X]2-C-[X]4-H-[X]4-C-)
that bind zinc ions, forming structures referred to as zinc fingers
(ZFs). NC proteins with native ZFs are required for viral replication
and are apparently utilized at many stages of the replication cycle.
The biological roles of retroviral NC proteins and their ZFs have been
reviewed recently (18, 19) and include functions during
viral assembly, maturation, and infection. Regarding particle
morphology, the basic residues of NC are required for consistent and
proper particle size (21), and the ZFs, when mutated or
deleted, result in virions that do not mature properly
(7). In fact, a number of the functions of NC are
attributed to the ZFs.
All human immunodeficiency virus type 1 (HIV-1) and simian
immunodeficiency virus (SIV) NC proteins contain two ZFs. It is currently believed that each ZF is required for viral replication; however, they are not necessarily equally required for each and every
specific function during the replication cycle. In HIV-1, the proximal
Zn2+ finger (ZF1) functions in genomic RNA incorporation,
viral core morphogenesis, and proviral DNA synthesis (44,
45), while the intact distal Zn2+ finger (ZF2) is
required for Gag polyprotein stability during proteolytic processing
(35). It is clear in HIV-1 that one finger cannot replace
the function of another (25), so there is some degree of
independence in ZF activity, but there is also an overlap of many of
the NC functions attributed to both ZFs (23, 35, 44, 45).
However, these functions may not be consistent among all NC proteins
that contain two ZFs.
The functions of HIV-1 and SIV NC ZFs are of particular interest
because of their vital roles in viral replication and their potential
as targets for viral inactivation (mutational as well as chemical
targets). At present, little work has been accomplished to address ZF
function in SIV (23). Because these viruses are presently
used in many of the in vivo models of HIV-1 disease and vaccination
(3, 29, 30, 39, 48) and the retroviral NC protein is
presently a recognized target for therapeutic (6) and
vaccine (2, 43) development, it is imperative to
understand the viral physiology dictated by this protein in the SIV
system. To address this, we have mutated the specific
Zn2+-binding Cys residues to Ser of each or both fingers of
SIV(Mne) NC to eliminate ion binding (8), yet maintain as
much of the protein conformation as possible. We have also deleted the
first 4 amino acids of each finger or the entire finger-linker sequence to assess finger function differences between the
Zn2+-coordinated conformation and primary amino acid
sequence conformation. In this report, we have focused only on SIV(Mne)
NC function relative to genomic RNA incorporation, Gag polyprotein
processing, particle formation, and maturation. Here we provide a
detailed analysis of the subtle differences in function attributed to,
but not unique to, the individual ZFs of SIV(Mne) NC.
 |
MATERIALS AND METHODS |
Mutagenesis and plasmid construction.
SIV(Mne) was isolated
and cloned as described previously (4). The generation of
the full-length proviral clone and deletion mutants of SIV(Mne) NC has
been described previously (23). The subclone pPP1
(23) of SIV(Mne) was used as a template for the generation
of point mutants of NC ZFs. The Cys coding sequences in the NC gene
were changed to Ser by site-directed mutagenesis (QuickChange
site-directed mutagenesis kit; Stratagene, La Jolla, Calif.) with
primers (obtained from Life Technologies, Rockville, Md.) designed
specifically for each ZF as follows (the mutagenic nucleotides are
underlined): ZF1 C
S, plus strand 5'-TAA GAG TTG GAA
TAG TGG GAA AGA GGG ACA CTC TGC AAG GCA AAG CAG
[5' end corresponding to nucleotide [nt] position 1705 of the
SIV(Mne) sequence; GenBank accession no. M32741], producing pPP1-4.1r;
and ZF2 C
S, plus strand 5'-GGC AGC TGG AAA
AGT GGA CAA ATG GGC CAT GTT ATG GCC AAA AGC C
[5' end corresponding to nt position 1769 of the SIV(Mne) sequence],
producing pPP1-6.15. Cys
Ser changes in both ZFs were introduced by
mutagenesis of pPP1-4.1r with the ZF2 C
S mutational oligonucleotide,
producing pPP1-4.1.5. All mutations were confirmed by nucleotide
sequencing and are noted in the 52-amino-acid SIV(Mne) NC protein
sequence (31) depicted in Fig.
1.

View larger version (33K):
[in this window]
[in a new window]
|
FIG. 1.
Protein sequence of WT and mutant SIV(Mne) NC proteins.
Zinc-coordinating residues are indicated with residue numbers. Dotted
lines indicate Zn2+ coordination. A dashed line indicates
deletions.
|
|
SIV coding sequences were transferred to mammalian expression
constructs that are all based in the pCEP4 expression vector
from
Invitrogen (Carlsbad, Calif.). A portion of the SIV(Mne)
proviral
sequence was excised from plasmid pRB130 (
23) at the
unique
BsiEI sites in the U3 region of the long terminal
repeats
(LTRs), producing a 9.4-kbp fragment. Plasmid pRB130 is an
expression
plasmid that has a full-length SIV(Mne) proviral clone
containing
a deletion in the coding sequence for the first four amino
acids
of NC ZF2 (

Cys33 to Cys36;

ZF2) (
23). The
BsiEI fragment was
blunt ended with T4 polymerase (Promega
Corp., Madison, Wis.)
and cloned into the unique
PvuII site
of pCEP4, producing pCEP4-

ZF2.
In order to manipulate the viral LTR
and promoter sequences, pBks5'LTRmne
was constructed containing the
SalI-
BamHI proviral fragment of
SIV(Mne) from
pRB130 [the
SalI site is contained in the uncharacterized
mammalian flanking sequence upstream of the 5' LTR, and the
BamHI
site is located in the SIV(Mne) coding sequence at nt
position
1329; GenBank accession no.
M37241] in the homologous sites
of pBluescriptKS+ pBks+; Stratagene). Next, pBks5'LTRmne was digested
with
StyI and blunt ended with T4 polymerase, and the
largest
StyI fragment was ligated with the blunt-ended
1,722-bp
SalI-
BanI
cytomegalovirus (CMV) enhancer
sequence from pCEP4 (nt 594 to
1316) in the U3 region of the 5' LTR in
pBks5'LTRmne. The resulting
plasmid was designated pBks5'LTRmne-eCMVs8,
in which the CMV enhancer
was ligated in the negative orientation (with
respect to the LTR),
because gene expression was greatest in this
conformation. The
final expression vector used in these studies,
designated pS8,
was generated by replacing the
NruI-
BamHI fragment of pCEP4-

ZF2
(which
removed the entire original CMV promoter-enhancer) with
an
EcoRV-
BamHI fragment from plasmid
pBks5'LTRmne-eCMVs8 containing
the CMV immediate-early enhancer
sequence (nt 594 to 1316 in pCEP4)
at the blunt-ended
StyI
site in the 5' LTR of SIV(Mne), thus retaining
the known NF-

B and
SpI binding sites in the 5' LTR, but removing
the sequence of the 5'
LTR upstream from the
StyI site. Each deletion
and point
mutation from the pPP1 series was introduced into pS8
by exchanging
BamHI-
Sse8387I fragments containing NC sequence.
In the 3' LTR, the known NF-

B and SpI binding sequences of U3,
as
well as the R and U5 regions, have been replaced with the simian
virus
40 (SV40) poly(A) signal, leaving the
nef sequence
intact.
Transfections.
293T cells were transfected as previously
described (26) with equimolar amounts of proviral plasmids
by calcium phosphate precipitation (5'
3', Inc., Boulder, Colo.).
Supernatants were harvested and clarified as previously described
(24).
Electron microscopy and particle analysis.
Supernatants from
transfected 293T cells were clarified by centrifugation, and virus was
pelleted at 100,000 × g through a 20% (wt/vol)
sucrose cushion in phosphate-buffered saline (PBS). Virus pellets were
fixed in 1.25% (vol/vol) glutaraldehyde in PBS. Electron microscopy
was performed with a Hitachi H-7000 microscope at 75 kV as previously
described (23). Six photographs were taken of each virus
pellet, with an average number of 119 virions per photo. Virus
particles (magnification of ×90,000) were digitized with a ScanAce III
scanner (Pacific Image Electronics Co., Ltd., Torrance, Calif.) at a
600-dpi resolution and processed with Adobe Photoshop (Adobe Systems,
Inc., Mountain View, Calif.).
SIV p28CA antigen capture assay.
Virus was
produced and pelleted as described above and then resuspended in PBS.
Serial dilutions of sample aliquots and standards were prepared and
assayed as previously described for aldrithiol-2-treated HIV
p24CA (43), except that the capture antibody
(AIDS Vaccine Program, Biological Products Laboratory [AVP-BPL]
inventory no. 0089A-9B5-8BE5-6AC10) and detector antibody (AVP-BPL
inventory no. DJ-40115, bleed 10263) were specific for SIV(Mne). Assay
standards were based on a wild-type (WT) SIV(Mne), clone E11S stock,
produced from infected HuT78 cells that had been accurately quantitated
by reversed-phase high-performance liquid chromatography (RP-HPLC) and
amino acid composition.
Viral protein western analysis.
Virus was produced and
pelleted as described above. Samples containing equivalent reverse
transcriptase (RT) activity (3.8 × 105 cpm by
exogenous template RT activity assay [27]) were
fractionated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) using 4 to 20% Tris-glycine Novex gels
(Invitrogen Corp.), immunoblotted as described previously
(25), and then incubated with mouse monoclonal
anti-p28CA antibodies (AVP-BPL inventory no. 96-0020 89A
P9B5 H8B1) and visualized with the Amersham ECL (enhanced
chemiluminescence) system (Arlington Heights, Ill.). Membranes were
stripped according to manufacturer's recommendations (Amersham ECL
system) and then incubated with rabbit polyclonal anti-gp120 and
anti-p8NC antibodies (AVP-BPL no. DJ-36603 003545 and
DJ-37545 005970, respectively) concomitantly and visualized with ECL as
well. Lyophilized fractions from RP-HPLC were fractionated by SDS-PAGE
and immunoblotted as described above. Membranes were sequentially
incubated no more than three times with rabbit polyclonal
anti-p28CA (no. B2119-5), anti-p8NC (no.
62837), anti-p6Gag (no. 63157), and anti-p2Gag
(no. 63158) antibodies supplied by Raoul Benveniste, Basic Research Laboratory, National Cancer Institute at Frederick, Frederick, Md. Each
hybridization was followed by ECL visualization. Blots were completely
stripped of all antisera before being reprobed with the next antibody.
RP-HPLC separation of SIV(Mne) WT and ZF mutant proteins.
Pelleted virus from equivalent supernatant volumes of transfected 293T
cultures was first resuspended in 50 µl of PBS and then reduced in 10 mM dithiothreitol (Calbiochem, La Jolla, Calif.) in the presence of 50 µl of 8 M sequenal-grade aqueous concentrate of high-purity
guanidine-HCl (Pierce, Rockford, Ill.) and 10% (vol/vol) acetonitrile
(EM Science, Gibbstown, N.J.) for 5 min at 37°C and loaded onto a
Poros R2/H narrow-bore column (2.1 by 100 mm) (PerSeptive Biosystems,
Inc., Framingham, Mass.). RP-HPLC was performed with a Shimadzu system
as described previously (36). Fractions were eluted at a
flow rate of 0.3 ml/min with a variable gradient of acetonitrile in
0.1% (vol/vol) Spectro-grade trifluoroacetic acid (Applied Biosystems,
Warrington, United Kingdom) as follows: from 10 to 36.5% (vol/vol)
acetonitrile for 12 min, 36.5 to 37% for 4 min, 37 to 41% for 7 min,
41 to 70% for 12 min, and 70% for 5 min. Peaks were detected by UV
absorption at 206, 280, and 260 nm and analyzed by sequencing with an
automated Applied Biosystems, Inc., Procise Protein Sequencer,
SDS-PAGE, and immunoblot detection with the ECL system (Amersham Life
Science). Fractions were collected every 30 s. Selected fractions
were also analyzed by matrix-assisted laser desorption ionization-time
of flight mass spectrometry as described previously (36).
Viral RNA analysis.
Viral RNA was prepared as previously
described (23). Samples were normalized for equivalent RT
activity (4.2 × 106 cpm) determined from pelleted
virus samples. RNA was electrophoresed through a formaldehyde-agarose
gel, transferred to a nitrocellulose membrane, and treated as described
previously (27). WT RNA was additionally analyzed at
dilutions of 1:4, 1:16, 1:64, and 1:128. The full-length WT SIV(Mne)
proviral plasmid pRB85 (23) was cut with XhoI
restriction enzyme, random-prime 32P labeled (DECAprimeII
kit; Ambion, Inc., Austin, Tex.), and used as a probe for full-length
genomic RNA. RNA blots were hybridized overnight at 42°C in a mixture
of 50% (vol/vol) formamide, 120 mM Na2HPO4 (pH
7.2), 250 mM NaCl, 7% (wt/vol) SDS, and the entire Sephadex G-50
(Amersham Pharmacia Biotech, Inc., Piscataway, N.J.) spin
column-purified labeled probe. Blots were washed as previously described (23). Phosphorimager analysis was performed with
bands of full-length genomic RNA with a Bio-Rad Molecular Imager FX phosphorimager with a K-Imaging Screen (Hercules, Calif.).
Quantitative RT-PCR was performed as previously described
(
23) with aliquots from RNA samples described
above.
 |
RESULTS |
Virion morphology.
To characterize the effect of the removal
of zinc-binding residues of NC on particle formation and maturation,
mutations were introduced into the SIV(Mne) viral coding sequence.
Specifically, the 52-amino-acid NC domain of Gag was altered to produce
the mutants listed in Fig. 1. Virus particles were produced from 293T cells by transfection of DNA plasmids containing the complete coding
sequence of WT or the various NC mutants of SIV(Mne). Virions were
collected by centrifugation and examined by electron microscopy with
positive staining. Electron micrographs were digitized so that
individual virions could be sorted according to specific morphological
criteria. Virus particles were isolated from two representative
photographs of each mutant and categorized as (i) mature morphology if
a condensed core and thin capsid membrane were observed; (ii) immature
morphology if a noncondensed core and thick capsid membrane were
observed, or (iii) abnormally large or small morphology if particles
deviated from the average 100-nm diameter of WT particles by greater
than 10% (Fig. 2). Particles were
excluded if they contained both characteristics and/or cores were not
visible because of the plane of thin sectioning (Table 1). Those particles of condensed core
morphology were subcategorized as (i) cone, or WT core of high electron
density; (ii) rod core of low electron density; or (iii) multiple
cores, all of which were rod morphologies.

View larger version (82K):
[in this window]
[in a new window]
|
FIG. 2.
Electron microscopic classification of virion
morphology. Three typical examples of each type of morphology (except
irregular large) are shown. The upper two virions in each category are
typical longitudinal cross-sections, and the lower virion in each
category is a typical latitudinal cross-section. Virus was pelleted
from clarified supernatants of 293T cells 72 h after transfection
with mutant or WT plasmid DNA. Images are digital and were scanned from
electron micrographs at a magnification of ×90,000.
|
|
An examination of the purified particles by electron microscopy showed
that the WT virus produced particles with normal dimensions
(~100 nm)
(Table
1), whereas all of the mutants had a significant
number of
abnormally large particles (12 to 26%) (Table
1). Larger-than-normal
particles probably result from abnormal function of the Gag precursor
during initial phases of assembly and budding. The fact that each
mutant shows a distribution of particle dimensions suggests that
both
normal and abnormal assembly paths are possible. It is interesting
to
note that point mutants or deletions which affect one ZF but
leave the
other intact (ZF1 mutants and ZF2 mutants) (Table
1)
show about the
same proportion of large particles (14% ± 3%).
Point mutations
destroying both ZFs (ZF1+2 C

S) (Table
1) produce
a slightly greater
proportion of large particles (20%), whereas
deletion of both ZFs
(

ZF1+2) resulted in a significant number
of abnormally small
particles (55%) in addition to an increased
proportion of large
particles (26%). These data show that from
the limited standpoint of
particle dimension, there is little
or no difference between the
mutants, except for mutant

ZF1+2
with both ZFs
deleted.
All of the mutants exhibited a higher proportion of normal-sized
particles with immature morphology (7 to 30%) than was observed
with
the WT virus (2%). The double deletion mutant,

ZF1+2, produced
very
few particles with normal dimensions (Table
1), and it was
therefore
difficult to assess the proportion of particles with
immature
morphologies.
The major differences between the normal-sized particles produced by
the various mutants examined in Table
1 were in the
morphology of
condensed cores. At least three distinctly different
condensed core
morphologies could be identified; condensed cores
with a WT cone shape;
condensed cores with a rod shape, and condensed
core with multiple
rods. Mutations in the first ZF (deletion or
point) gave the highest
proportion of particles with WT cores
(14 to 17%), but most of the
condensed cores were rod shaped.
Mutations in the second ZF (deletion
or point) gave an even higher
proportion of particles with rod-shaped
cores and very few particles
with WT-shaped
cores.
Taken together, these results show that deletion of both ZFs and the
linker region between ZFs (

ZF1+2) dramatically reduces
the number of
normal-sized particles and is consistent with previous
observations
stressing the importance of the linker in particle
formation (
10,
14,
21,
37). The ZFs seem to play an important
role in
determining the extent of maturation and morphology of
the condensed
core. Mutations affecting either ZF increase the
number of immature
forms and the number of particles with rod-shaped
cores.
Virus particle production.
To determine the ratio of
particle-associated Gag-Pol polyprotein to Gag produced by the NC
mutant and WT transfections, virus was quantitated by RT activity in an
exogenous template assay (to estimate Gag-Pol levels) and Gag
expression through a p28CA antigen capture assay. Table
2 shows that the Gag-Pol/Gag ratios are
relatively constant among the mutant and WT viruses, except for the
ZF1+2 mutant. RT activity was measured in viral pellets as well as
polyethylene glycol (PEG)-precipitated culture supernatants to observe
any differences in particle-associated and supernatant RT. These
results are also summarized in Table 2. All mutants demonstrate similar
ratios of particle-associated to supernatant RT levels.
Genomic RNA incorporation.
To determine if the morphological
differences observed could be attributed to variations of full-length
genomic RNA incorporation, particle-associated RNA was isolated and
analyzed by Northern blotting and quantitative RT-PCR (Fig.
3) (23). It appears that the
alteration of NC ZF1 does not significantly affect genomic RNA
incorporation, yet the alteration of NC ZF2 results in reduced incorporation of full-length genomic RNA. Similar to the
ZF1+2 mutant (23), ZF1+2 C
S incorporates <20% WT levels of
full-length genomic RNA. These results suggest that there is no
correlation between genomic RNA incorporation and viral core
condensation. While it is apparent that loss of zinc coordination
results in some reduction of genomic RNA encapsidation
and ZF2 appears
to function in this capacity more so than ZF1
the observations with the
ZF1+2 mutant suggest that it is the linker region and basic charge of NC that influence genomic RNA encapsidation the greatest.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 3.
Analysis of genomic RNA incorporation into WT and NC
mutant SIV(Mne) virions. Virus was pelleted from clarified supernatants
of transfected 293T cells, and viral RNA was isolated by
phenol-chloroform extraction-ethanol precipitation. Samples, equalized
for pelletable RT activity, were probed with the pRB85 vector
containing full-length SIV(Mne) that had been linearized with
XhoI and then labeled with 32P
(23). The mock control lane contains an RNA preparation
from carrier DNA-transfected 293T supernatants. Full-length genomic RNA
(9.6 kbp) indicated on the left was quantitated by phosphorimaging (PI)
and quantitative real-time RT-PCR (PCR). Positions of RNA markers are
shown on the right. ND, not determined.
|
|
Polyprotein processing.
To determine if improper or incomplete
proteolytic cleavage of the Gag, Gag-Pol, and Env polyproteins could be
associated with the observed morphological differences, WT and mutant
viruses were examined by Western analysis and fractionation by RP-HPLC. Because this laboratory focuses on the development of novel vaccines against HIV and SIV, a plasmid vector (pS8) was designed for use as a
naked DNA vaccine. pS8 consists of the full-length SIV(Mne) coding
sequence, but the LTRs have been partially deleted (see Materials and
Methods) for increased in vivo safety purposes. Briefly, the R and U5
regions in the 3' LTR have been replaced by an exogenous SV40
polyadenylation sequence to prevent first-strand transfer during viral
DNA synthesis, yet provide the polyadenylation necessary for proper
viral gene expression. The LTR deletions, in combination with the
specific NC mutations, render these viruses replication incompetent
(data not shown). Because of the changes in LTR structure in the pS8
expression vector, it was necessary to demonstrate that particle
assembly and polyprotein processing were not affected. Viral proteins
of the WT and an example of one of the NC mutants,
ZF2, were
compared in the context of the pS8 vector or a complete proviral vector
(Fig. 4). By gp120SU,
p28CA, and p8NC Western analysis, no
significant differences in polyprotein processing were observed if the
LTR sequences were altered as described for the pS8 vector. While these
LTR modifications decrease infectivity at least 3 logs in the clone
containing WT NC (data not shown), Fig. 4 demonstrates that the
processing differences observed were clearly the result of the mutation
present in the NC domain and were not due to the LTR alterations.

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 4.
Immunoblot comparison of viral protein processing with
complete or deleted LTR ends. WT or ZF2 mutant SIV(Mne) virus was
produced by transfection of 293T cells with plasmids containing
complete LTRs (provirus [PV]) or deleted LTRs (S8) as described in
Materials and Methods. Virus pelleted from clarified supernatants
72 h after transfection was resuspended in SDS-PAGE lysis buffer
and then subjected to Western blot analysis. Protein samples were
adjusted to equivalent RT activity before SDS-PAGE. Blots were
initially incubated with mouse monoclonal p28CA antibody
(A) and then stripped and reprobed concomitantly with rabbit polyclonal
gp120 and p8NC antibodies (B). Molecular markers are
indicated on the left, and immunodetected proteins are indicated on the
right.
|
|
To compare WT and mutant polyprotein processing, immunoblot analysis
was performed with pelleted virus (Fig.
5). All mutants
were able to process Env
polyprotein similar to the WT (Fig.
5B).
However, the degree of Gag
processing was subtly different, depending
on the ZF mutation (Fig.
5).
Deletion and point mutations in ZF2
resulted in the highest
accumulation of unprocessed Gag, while
mutations in ZF1 resulted in
less accumulation of unprocessed
Gag. Point mutations in both ZFs
resulted in accumulation of unprocessed
Gag similar to ZF2 mutations.
All mutants except for

ZF1+2 produced
a significant amount of
slower-migrating p28
CA (designated p30
Gag; Fig.
5A), which is presumably unprocessed
p28
CA-p2
Gag. Also, an additional NC-reactive
band was observed (p9
Gag; Fig.
5B) that is presumably
unprocessed p8
NC-p1
Gag. Surprisingly, the
smallest amount of unprocessed Gag was observed
with

ZF1+2; however,
this mutant also contained significantly
higher levels of
virus-associated gp120
SU (Fig.
5B) and no detectable NC
protein (Fig.
5B and
6), possibly
due to
the loss of reactive epitopes in the deleted sequence.
Interestingly,
only point mutants of ZF2 or ZF1+2 produced NC-containing
proteins of
slower mobility. From these data, it can be summarized
that alteration
of ZF2 results in more unprocessed Gag than alteration
of ZF1, but the
removal of both ZFs and the basic linker results
in very efficient Gag
cleavage.

View larger version (58K):
[in this window]
[in a new window]
|
FIG. 5.
Immunoblot analysis of viral protein processing in WT
and NC mutant SIV(Mne). Virus was pelleted as described in Materials
and Methods and resuspended in SDS-PAGE lysis buffer. Samples of
equivalent RT activity (3.8 × 105 cpm by exogenous
template RT assay) were heat denatured, subjected to 4 to 20%
SDS-PAGE, and transferred to Immobilon-P (Millipore Corp.). Membranes
were probed with mouse monoclonal p28CA antibodies and
visualized with the Amersham ECL system (A). Membranes were stripped
and reprobed with rabbit anti-gp120 and p8NC concomitantly
and visualized with ECL as well (B). Molecular mass markers are shown
on the left, and immunolabeled proteins are shown on the right.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 6.
RP-HPLC analysis of WT and NC mutant SIV(Mne). Virus was
pelleted from 30 ml of clarified culture supernatant of 293T cells
transfected with WT or NC mutant expression plasmids and then
resuspended in PBS in the presence of 8 M guanidine-HCl, 10%
acetonitrile, and 10 mM dithiothreitol. Equivalent volumes were loaded
on a microbore RP-HPLC column and eluted as described in Materials and
Methods. Chromatographs are grouped according to the ZF mutation for
ease of comparison. The acetonitrile concentration is superimposed over
the WT chromatograph. Viral protein peaks were determined by Coomassie
staining, immunoblotting, and protein sequencing analyses of eluted
fractions and are labeled accordingly: NC, nucleocapsid protein; p1/p2,
spacer protein 1 and spacer protein 2 of Gag polyprotein; MA, matrix;
and CA, capsid. An asterisk indicates contamination of the
p6Gag peak with an unidentified cellular protein in the
ZF1+2 chromatograph.
|
|
To quantitate relative amounts of viral proteins and determine the
nature of unprocessed Gag polyproteins, WT and mutant virus
was
pelleted and subjected to RP-HPLC fractionation and various
peptide
analyses. RP-HPLC fractions were collected and subsequently
analyzed by
Western blotting with antisera to specific Gag proteins.
The ability to
separate and identify viral proteins in this manner
allows much more
accurate quantitation than conventional Western
analysis of whole viral
preparations. Chromatographs comparing
WT and mutant virus are shown in
Fig.
6. Two significant observations
were noted. First, the peak height
of the eluted NC protein relative
to other processed Gag proteins
(p1
Gag/p2
Gag, p6
Gag,
p16
MA, and p28
CA) is reduced and shifted to the
left in chromatographs of the
mutants where NC is detectable, compared
to that in the WT. Mutations
in ZF2 or both ZFs resulted in less NC
protein than mutations
in ZF1. Confirming the results presented in Fig.
5B, NC protein
is undetectable in

ZF1+2 by RP-HPLC. These results
show that
there is a significant loss of the processed p8
NC
protein in all
mutants.
The second significant observation in the chromatographs in Fig.
6 is
the relative increase of two peaks following elution
of
p28
CA (e.g.,

ZF2). Because these peaks might be the
accumulated unprocessed
Gag polyproteins observed in the Western
analyses (Fig.
5), fractions
were collected, fractionated by SDS-PAGE,
and analyzed by Coomassie
staining and Western analysis. Figure
7 shows an example of an
analysis of a
representative mutant,

ZF2, showing the portion
of the chromatograph
following elution of p6
Gag. Fractionated proteins in the
peaks were separated by SDS-PAGE,
visualized by Coomassie staining, and
determined to consist of
four major proteins (I to IV in Fig.
7A).
Next, the same fractions
were blotted and tested for reactivity to
antisera against p28
CA, p2
Gag,
p8
NC, and p6
Gag (Fig.
7B). Because available
anti-p16
MA antibodies did not recognize p16
MA
epitopes in the Gag precursor, the presence of the p16
MA
domain was confirmed in some fractions by proteolytic digestion
and
peptide sequencing. Also, the anti-p2
Gag antibodies only
recognized p2
Gag epitopes in completely processed
p2
Gag or when the Gag precursor was cleaved at the
p2
Gag-p8
NC junction (i.e., a p2
Gag
with a free C terminus). For example, protein III in Fig.
7A
reacted
with antibodies to p2
Gag and p28
CA, but not to
p8
NC or p6
Gag (Fig.
7B); it contained
p16
MA peptide sequence; and it was approximately 44 kDa in
size. Therefore,
it was concluded that protein III was a partially
processed Gag
precursor consisting of MA, CA, and p2
Gag
(Fig.
7C). Fractions across the entire RP-HPLC were analyzed
for Gag
precursors by Western blotting, but no peaks other than
I to IV
contained partially processed or uncleaved Gag polyproteins.
From these
results, the elution and consistency of partially processed
and
uncleaved viral Gag polyproteins were identified and diagrammed
as
proteins I to IV in Fig.
7C. All mutant particles contained
the same
molecules of Gag proteins I to IV, but in different proportions,
as
observed by peak heights of proteins I to IV relative to the
other,
fully processed Gag proteins within the same chromatograph
(Fig.
6).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 7.
SDS-PAGE and immunoblot analysis of incomplete Gag
polyprotein processing. (A) A section of the chromatograph from Fig. 6
( ZF2) showing an example of the NC mutant, ZF2, RP-HPLC, and
numbered protein fractions that were fractionated by SDS-PAGE and
visualized with Coomassie stain. Four distinct proteins (I to IV) were noted in peaks more prominent in the NC mutant than in
the WT SIV(Mne) chromatographs. (B) Immunoblot analyses of fractions
for anti-p28CA, anti-p2Gag,
anti-p8NC, and anti-p6Gag antibodies. Molecular
markers are shown on the left; the positions of labeled proteins I to
IV are indicated on the right. Note that the p2Gag antibody
only recognizes a cleaved or C-terminal epitope. (C) Identity of
incompletely processed Gag proteins I to IV based on Coomassie,
immunoblot, and partial amino acid sequence analyses. The same Gag
polyproteins I to IV were observed in all NC mutants, only in different
amounts.
|
|
To quantify the relative loss of NC protein in the mutant virions, the
peak areas of fully processed (Fig.
6) and partially
processed NC (Fig.
7, peaks I and II) were compared to those of
processed (Fig.
6) and
unprocessed CA (Fig.
7, peaks I to IV)
within each of the mutants and
the WT. The results were expressed
as a ratio of processed NC to
processed CA and p6
Gag to CA in Table
3. The majority of detectable mutant NC
that
is present in the virion is in the form of uncleaved and partially
processed Gag precursor (72 to 99%), whereas the majority of
detectable
WT NC is fully processed (86%). In the mutant virions, CA
is present
approximately equally in fully and partially processed forms
(41
to 70%). The mutant virions contained a greater variation in the
levels of processed and unprocessed p6
Gag. As expected, the
relative ratio of processed CA to processed
NC in WT is nearly 1:1
(0.94), as is processed CA to processed
p6
Gag; however,
NC/CA ratios in the mutants demonstrate a significant
loss of processed
NC. At present, it cannot be stated whether
this apparent loss of NC
protein is due to proteolytic degradation
or alternative NC processing
into smaller fragments, but no detectable
fragments of mutant NC
protein were eluted from the RP-HPLC column
under the conditions
described.
 |
DISCUSSION |
While previous studies of SIV have focused on genomic RNA
encapsidation and general viral protein production and processing in
relation to NC ZFs, we show for the first time that subtle differences
in virion morphology can be attributed to the Zn2+
coordination of each finger. Specifically, proper core condensation is
severely disrupted by mutation of ZF2, whereas mutation of ZF1 disrupts
this process to a lesser extent (Table 1 and Fig. 2). We utilized
SIV(Mne) NC mutants (Fig. 1) that inhibit zinc binding by either
changing specific zinc-coordinating Cys residues to Ser or deleting the
first four amino acids in each or both fingers, including the basic
linker sequence. Our results support previous reports that the two
finger arrays of retroviral NC proteins exert different activities, yet
do not function independently (9, 13, 25, 35). However,
our analyses of SIV NC ZF function differ from those reported for other
retroviruses, such as HIV, murine leukemia virus, and Rous sarcoma
virus (16, 41, 44, 45). In agreement with previous reports
(12, 40), we found that genomic RNA incorporation (Fig. 3)
is less dependent on Zn2+ coordination, but is more
dependent on the basic charge of NC. However, contrary to observations
with HIV-1, we found that it is ZF2 that affects RNA encapsidation more
than ZF1.
The results from the RP-HPLC analyses (Fig. 6) support those of the
immunoblot assays (Fig. 5 and 7): complete proteolytic cleavage of Gag
is associated with proper core condensation. The RP-HPLC results go two
steps further to indicate that (i) the removal of the Zn2+
from the NC protein results in a reduction in processed NC protein when
compared to all possible Gag cleavage products in each mutant (Fig. 6,
compare relative peak heights of Gag cleavage products containing NC
with peaks of other cleavage products that do not contain NC) and (ii)
the unprocessed Gag polyproteins occur in four major forms. Gag
cleavage is an ordered process that is necessary to produce
morphologically mature virions (17, 38, 50). Incomplete
processing of Gag due to conformation, protein-protein, and/or
protein-nucleic acid interactions resulting from the loss of
Zn2+ in our NC ZF mutants may be responsible for the
inability of virion cores to properly condense as has been suggested
previously in HIV studies (28, 32, 33, 47). To our
knowledge, Gag-Gag interaction domains (I domains) (10)
have not been studied in SIV. While it is possible that the mutations
discussed here may alter protein conformation, the number of basic
residues of the NC in the ZF1+2 C
S mutant is the same as that in the
WT NC, yet this mutant produces a significant amount of partially
processed and uncleaved Gag with some full-length genomic RNA
encapsidation. Therefore, effects on the I domains would have to be due
to altered conformation of the protein. An altered conformation could
result from (i) a "loose" folding of Gag in the NC domain due to
the lack of Zn2+ coordination of the ZFs or (ii) a
"reconfigured" folding of the NC domain due to (a) possible
Zn2+ coordination between the remaining His and Cys
residues in the deleted ZF and those in the complete ZF and/or (b)
possible disulfide bond formation in the single-finger deletion
mutants. Disulfide bonds do indeed form when the Zn2+ ions
are ejected from the ZF of WT NC in HIV and SIV (2, 43).
NC in an altered conformation resulting from the loss of the
Zn2+ in either or both fingers may be open to extensive
proteolytic cleavage, most likely from the viral protease. The
significant loss of mutant NC protein observed in the RP-HPLC (Fig. 6
and Table 2) suggests this scenario. Previous studies have demonstrated protease-specific NC cleavage in HIV-1 and equine infectious anemia virus (42, 46) and that the removal of the
Zn2+ is necessary for this cleavage (51). The
destruction of NC early in virus formation would surely have a profound
effect on downstream events in the life cycle that are known to require NC, including RNA stability, reverse transcription, and, possibly, integration of the viral genome.
NC protein is present in isolated mature conical HIV-1 cores
(49) and has been shown to be required for the
condensation of viral protein with nucleic acid to a conical core
phenotype in in vitro assembly systems (11, 20). Our
results show that genomic RNA incorporation in ZF2 C
S and
ZF2 is
not severely reduced, but relative levels of unprocessed Gag are much
higher than those in the ZF1 C
S and
ZF1 mutants (Fig. 3). Yet
there is a striking difference in the number of particles with properly condensed cores between virions with ZF1 and ZF2 mutations, suggesting the differences in core morphology are dictated more by Gag cleavage than full-length genomic RNA encapsidation. However, these associations cannot be stated independently, because at least one other factor, the
basic charge of NC, is known to affect virion morphology. Although
ZF1+2 virions contained more fully processed Gag, it contained very
little detectable full-length genomic RNA by Northern blotting
(23), whereas the ZF1+2 C
S mutant produced a profile of
Gag processing similar to those of ZF2 C
S and
ZF2 and also had
severely reduced levels of virion-associated full-length genomic RNA.
Cimarelli et al. (12) demonstrated the relationship
between the basic charge of NC, RNA incorporation, and virion
morphology in HIV-1. Their HIV-1 mutants BR and M1-2/BR contained
little and no viral or cellular RNA, respectively, and produced
irregular large and small virions with multiple rod-shaped cores
similar to those produced by the
ZF1+2 mutant. The requirement for
nucleic acid in virion core morphology suggests that mutants lacking
viral RNA may substitute nonspecific cellular RNA to achieve a
condensed core (5).
Previous studies have only demonstrated that mutations in NC protein
inhibit virion maturation (6, 7, 23, 35, 45). The negative
effect of the ZF mutations on complete Gag processing may suggest an
upstream role for NC in the complete process of virion maturation,
since Gag mutations outside of the NC domain that result in improper or
incomplete proteolytic processing also affect virion core condensation
(1, 15, 22, 34, 47, 50). Indeed, there is a correlation
between the presence of p30Gag (Fig. 5A) and an increase in
immature virions (Table 1). Whether the NC protein in this process is
active (Zn2+ transfer or release) or passive (structural
conformation or dimerization) remains to be elucidated.
 |
ACKNOWLEDGMENTS |
Kunio Nagashima at SAIC Electron Microscopy Laboratory,
Frederick, Md., performed electron microscopy. We thank Raoul
Benveniste (NCI, Basic Research Laboratory) for the SIV(Mne) antisera
used for immunoblot analyses, Terra Schaden for technical expertise with p28CA antigen capture analysis, and Michael Piatak,
Jr., who performed the real-time RT-PCR measurements with virion RNA.
We also thank David Ott, Dexter Poon, and Larry Arthur for constructive
criticism in writing the manuscript.
This work was supported by NIH contract NO1-CO-56000 with
SAIC-Frederick.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: AIDS Vaccine
Program, SAIC-Frederick, National Cancer Institute, Frederick, MD
21702-1201. Phone: (301) 846-5980. Fax: (301) 846-7119. E-mail:
gorelick{at}avpaxp1.ncifcrf.gov.
 |
REFERENCES |
| 1.
|
Accola, M. A.,
S. Höglund, and H. G. Göttlinger.
1998.
A putative -helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
J. Virol.
72:2072-2078[Abstract/Free Full Text].
|
| 2.
|
Arthur, L. O.,
J. W. Bess, Jr.,
E. N. Chertova,
J. L. Rossio,
M. T. Esser,
R. E. Benveniste,
L. E. Henderson, and J. D. Lifson.
1998.
Chemical inactivation of retroviral infectivity by targeting nucleocapsid protein zinc fingers: a candidate SIV vaccine.
AIDS Res. Hum. Retrovir.
14(Suppl. 3):S311-S319.
|
| 3.
|
Arthur, L. O.,
J. W. Bess, Jr.,
R. G. Urban,
J. L. Strominger,
W. R. Morton,
D. L. Mann,
L. E. Henderson, and R. L. Benveniste.
1995.
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.
J. Virol.
69:3117-3124[Abstract].
|
| 4.
|
Benveniste, R. E.,
L. O. Arthur,
C.-C. Tsai,
R. Sowder,
T. D. Copeland,
L. E. Henderson, and S. Oroszlan.
1986.
Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses.
J. Virol.
60:483-490[Abstract/Free Full Text].
|
| 5.
|
Berkowitz, R.,
J. Fisher, and S. P. Goff.
1996.
RNA packaging.
Curr. Top. Microbiol. Immunol.
214:177-218[Medline].
|
| 6.
|
Berthoux, L.,
C. Péchoux, and J.-L. Darlix.
1999.
Multiple effects of an anti-human immunodeficiency virus nucleocapsid inhibitor on virus morphology and replication.
J. Virol.
73:10000-10009[Abstract/Free Full Text].
|
| 7.
|
Berthoux, L.,
C. Péchoux,
M. Ottmann,
G. Morel, and J.-L. Darlix.
1997.
Mutations in the N-terminal domain of human immunodeficiency virus type 1 nucleocapsid protein affect virion core structure and proviral DNA synthesis.
J. Virol.
71:6973-6981[Abstract].
|
| 8.
|
Bess, J. W., Jr.,
P. J. Powell,
H. J. Issaq,
L. J. Schumack,
M. K. Grimes,
L. E. Henderson, and L. O. Arthur.
1992.
Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses.
J. Virol.
66:840-847[Abstract/Free Full Text].
|
| 9.
|
Bowles, N. E.,
P. Damay, and P.-F. Spahr.
1993.
Effect of rearrangements and duplications of the Cys-His motifs of Rous sarcoma virus nucleocapsid protein.
J. Virol.
67:623-631[Abstract/Free Full Text].
|
| 10.
|
Bowzard, J. B.,
R. P. Bennett,
N. K. Krishna,
S. M. Ernst,
A. Rein, and J. W. Wills.
1998.
Importance of basic residues in the nucleocapsid sequence for retrovirus Gag assembly and complementation rescue.
J. Virol.
72:9034-9044[Abstract/Free Full Text].
|
| 11.
|
Campbell, S., and V. M. Vogt.
1995.
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
J. Virol.
69:6487-6497[Abstract].
|
| 12.
|
Cimarelli, A.,
S. Sandin,
S. Höglund, and J. Luban.
2000.
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.
J. Virol.
74:3046-3057[Abstract/Free Full Text].
|
| 13.
|
Dannull, J.,
A. Surovoy,
G. Jung, and K. Moelling.
1994.
Specific binding of HIV-1 nucleocapsid protein to PSI RNA in vitro requires N-terminal zinc finger and flanking basic amino acid residues.
EMBO J.
13:1525-1533[Medline].
|
| 14.
|
Dawson, L., and X. F. Yu.
1998.
The role of nucleocapsid of HIV-1 in virus assembly.
Virology
251:141-157[CrossRef][Medline].
|
| 15.
|
Dorfman, T.,
A. Bukovsky,
Å. Öhagen,
S. Höglund, and H. G. Göttlinger.
1994.
Functional domains of the capsid protein of human immunodeficiency virus type 1.
J. Virol.
68:8180-8187[Abstract/Free Full Text].
|
| 16.
|
Dupraz, P.,
S. Oertle,
C. Meric,
P. Damay, and P.-F. Spahr.
1990.
Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein.
J. Virol.
64:4978-4987[Abstract/Free Full Text].
|
| 17.
|
Erickson-Viitanen, S.,
J. Manfredi,
P. Viitanen,
D. E. Tribe,
R. Tritch,
C. A. D. Hutchison,
D. D. Loeb, and R. Swanstrom.
1989.
Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease.
AIDS Res. Hum. Retrovir.
5:577-591[Medline].
|
| 18.
|
Frankel, A. D., and J. A. Young.
1998.
HIV-1: fifteen proteins and an RNA.
Annu. Rev. Biochem.
67:1-25[CrossRef][Medline].
|
| 19.
|
Freed, E. O.
1998.
HIV-1 gag proteins: diverse functions in the virus life cycle.
Virology
251:1-15[CrossRef][Medline].
|
| 20.
|
Ganser, B. K.,
S. Li,
V. Y. Klishko,
J. T. Finch, and W. I. Sundquist.
1999.
Assembly and analysis of conical models for the HIV-1 core.
Science
283:80-83[Abstract/Free Full Text].
|
| 21.
|
Garnier, L.,
L. Ratner,
B. Rovinski,
S.-X. Cao, and J. W. Wills.
1998.
Particle size determinants in the human immunodeficiency virus type 1 Gag protein.
J. Virol.
72:4667-4677[Abstract/Free Full Text].
|
| 22.
|
Gay, B.,
J. Tournier,
N. Chazal,
C. Carriere, and P. Boulanger.
1998.
Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells.
Virology
247:160-169[CrossRef][Medline].
|
| 23.
|
Gorelick, R. J.,
R. E. Benveniste,
T. D. Gagliardi,
T. A. Wiltrout,
L. K. Busch,
W. J. Bosche,
L. V. Coren,
J. D. Lifson,
P. J. Bradley,
L. E. Henderson, and L. O. Arthur.
1999.
Nucleocapsid protein zinc-finger mutants of simian immunodeficiency virus strain mne produce virions that are replication defective in vitro and in vivo.
Virology
253:259-270[CrossRef][Medline].
|
| 24.
|
Gorelick, R. J.,
D. J. Chabot,
D. E. Ott,
T. D. Gagliardi,
A. Rein,
L. E. Henderson, and L. O. Arthur.
1996.
Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid domain: replacement of zinc-coordinating residues with other zinc-coordinating residues yields noninfectious particles containing genomic RNA.
J. Virol.
70:2593-2597[Abstract].
|
| 25.
|
Gorelick, R. J.,
D. J. Chabot,
A. Rein,
L. E. Henderson, and L. O. Arthur.
1993.
The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.
J. Virol.
67:4027-4036[Abstract/Free Full Text].
|
| 26.
|
Gorelick, R. J.,
T. D. Gagliardi,
W. J. Bosche,
T. A. Wiltrout,
L. V. Coren,
D. J. Chabot,
J. D. Lifson,
L. E. Henderson, and L. O. Arthur.
1999.
Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
Virology
256:92-104[CrossRef][Medline].
|
| 27.
|
Gorelick, R. J.,
S. M. Nigida, Jr.,
J. W. Bess, Jr.,
L. O. Arthur,
L. E. Henderson, and A. Rein.
1990.
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA.
J. Virol.
64:3207-3211[Abstract/Free Full Text].
|
| 28.
|
Gross, I.,
H. Hohenberg,
T. Wilk,
K. Wiegers,
M. Grattinger,
B. Muller,
S. Fuller, and H. G. Krausslich.
2000.
A conformational switch controlling HIV-1 morphogenesis.
EMBO J.
19:103-113[CrossRef][Medline].
|
| 29.
|
Haigwood, N. L.,
C. C. Pierce,
M. N. Robertson,
A. J. Watson,
D. C. Montefiori,
M. Rabin,
J. B. Lynch,
L. Kuller,
J. Thompson,
W. R. Morton,
R. E. Benveniste,
S. L. Hu,
P. Greenberg, and S. P. Mossman.
1999.
Protection from pathogenic SIV challenge using multigenic DNA vaccines.
Immunol. Lett.
66:183-188[CrossRef][Medline].
|
| 30.
|
Hanke, T.,
R. V. Samuel,
T. J. Blanchard,
V. C. Neumann,
T. M. Allen,
J. E. Boyson,
S. A. Sharpe,
N. Cook,
G. L. Smith,
D. I. Watkins,
M. P. Cranage, and A. J. McMichael.
1999.
Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen.
J. Virol.
73:7524-7532[Abstract/Free Full Text].
|
| 31.
|
Henderson, L. E.,
R. E. Benveniste,
R. Sowder,
T. D. Copeland,
A. M. Schultz, and S. Oroszlan.
1988.
Molecular characterization of gag proteins from simian immunodeficiency virus (SIVMne).
J. Virol.
62:2587-2595[Abstract/Free Full Text].
|
| 32.
|
Kräusslich, H. G.,
M. Fäcke,
A.-M. Heuser,
J. Konvalinka, and H. Zentgraf.
1995.
The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity.
J. Virol.
69:3407-3419[Abstract].
|
| 33.
|
Liang, C.,
L. Rong,
E. Cherry,
L. Kleiman,
M. Laughrea, and M. A. Wainberg.
1999.
Deletion mutagenesis within the dimerization initiation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins.
J. Virol.
73:6147-6151[Abstract/Free Full Text].
|
| 34.
|
Mammano, F.,
Å. Öhagen,
S. Höglund, and H. G. Göttlinger.
1994.
Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis.
J. Virol.
68:4927-4936[Abstract/Free Full Text].
|
| 35.
|
Mizuno, A.,
E. Ido,
T. Goto,
T. Kuwata,
M. Nakai, and M. Hayami.
1996.
Mutational analysis of two zinc finger motifs in HIV type 1 nucleocapsid proteins: effects on proteolytic processing of Gag precursors and particle formation.
AIDS Res. Hum. Retrovir.
12:793-800[Medline].
|
| 36.
|
Ott, D. E.,
E. N. Chertova,
L. K. Busch,
L. V. Coren,
T. D. Gagliardi, and D. G. Johnson.
1999.
Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6Gag protein produces a mutant that fails to package its envelope protein.
J. Virol.
73:19-28[Abstract/Free Full Text].
|
| 37.
|
Ottmann, M.,
C. Gabus, and J.-L. Darlix.
1995.
The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity.
J. Virol.
69:1778-1784[Abstract].
|
| 38.
|
Pettit, S. C.,
M. D. Moody,
R. S. Wehbie,
A. H. Kaplan,
P. V. Nantermet,
C. A. Klein, and R. Swanstrom.
1994.
The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions.
J. Virol.
68:8017-8027[Abstract/Free Full Text].
|
| 39.
|
Polacino, P. S.,
V. Stallard,
J. E. Klaniecki,
S. Pennathur,
D. C. Montefiori,
A. J. Langlois,
B. A. Richardson,
W. R. Morton,
R. E. Benveniste, and S.-L. Hu.
1999.
Role of immune responses against the envelope and the core antigens of simian immunodeficiency virus SIVmne in protection against homologous cloned and uncloned virus challenge in macaques.
J. Virol.
73:8201-8215[Abstract/Free Full Text].
|
| 40.
|
Poon, D. T. K.,
J. Wu, and A. Aldovini.
1996.
Charged amino acid residues of human immunodeficiency virus type 1 nucleocapsid p7 protein involved in RNA packaging and infectivity.
J. Virol.
70:6607-6616[Abstract/Free Full Text].
|
| 41.
|
Rein, A.,
D. P. Harvin,
J. Mirro,
S. M. Ernst, and R. J. Gorelick.
1994.
Evidence that a central domain of nucleocapsid protein is required for RNA packaging in murine leukemia virus.
J. Virol.
68:6124-6129[Abstract/Free Full Text].
|
| 42.
|
Roberts, M. M.,
T. D. Copeland, and S. Oroszlan.
1991.
In situ processing of a retroviral nucleocapsid protein by the viral proteinase.
Protein Eng.
4:695-700[Abstract/Free Full Text].
|
| 43.
|
Rossio, J. L.,
M. T. Esser,
K. Suryanarayana,
D. K. Schneider,
J. W. Bess, Jr.,
G. M. Vasquez,
T. A. Wiltrout,
E. Chertova,
M. K. Grimes,
Q. Sattentau,
L. O. Arthur,
L. E. Henderson, and J. D. Lifson.
1998.
Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.
J. Virol.
72:7992-8001[Abstract/Free Full Text].
|
| 44.
|
Schwartz, M. D.,
D. Fiore, and A. T. Panganiban.
1997.
Distinct functions and requirements for the Cys-His boxes of the human immunodeficiency virus type 1 nucleocapsid protein during RNA encapsidation and replication.
J. Virol.
71:9295-9305[Abstract].
|
| 45.
|
Tanchou, V.,
D. Decimo,
C. Péchoux,
D. Lener,
V. Rogemond,
L. Berthoux,
M. Ottmann, and J.-L. Darlix.
1998.
Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.
J. Virol.
72:4442-4447[Abstract/Free Full Text].
|
| 46.
|
Tozer, J.,
D. Friedman,
I. Weber,
I. Blaha, and S. Oroszlan.
1993.
Studies on the substrate specificity of the proteinase of equine infectious anemia virus using oligopeptide substrates.
Biochemistry
32:3347-3353[CrossRef][Medline].
|
| 47.
|
von Schwedler, U. K.,
T. L. Stemmler,
V. Y. Klishko,
S. Li,
K. H. Albertine,
D. R. Davis, and W. Sundquist.
1998.
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
EMBO J.
17:1555-1568[CrossRef][Medline].
|
| 48.
|
Wang, S.-W.,
G. Schmelz,
P. A. Kozlowski,
K. Manson,
M. S. Wyand,
R. Glickman,
D. Montefiori,
J. D. Lifson,
R. P. Johnson,
M. R. Neutra, and A. Aldovini.
2000.
Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions.
J. Virol.
74:10514-10522[Abstract/Free Full Text].
|
| 49.
|
Welker, R.,
H. Heinrich,
U. Tessmer,
C. Huckhagel, and H.-G. Kräusslich.
2000.
Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1.
J. Virol.
74:1168-1177[Abstract/Free Full Text].
|
| 50.
|
Wiegers, K.,
G. Rutter,
H. Kottler,
U. Tessmer,
H. Hohenberg, and H. G. Kräusslich.
1998.
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations in individual Gag polyprotein cleavage sites.
J. Virol.
72:2846-2854[Abstract/Free Full Text].
|
| 51.
|
Wondrak, E. M.,
K. Sakaguchi,
W. G. Rice,
E. Kun,
A. R. Kimmel, and J. M. Louis.
1994.
Removal of zinc is required for processing of the mature nucleocapsid protein of human immunodeficiency virus, type 1, by the viral protease.
J. Biol. Chem.
269:21948-21950[Abstract/Free Full Text].
|
Journal of Virology, January 2001, p. 115-124, Vol. 75, No. 1
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.1.115-124.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Muriaux, D., Costes, S., Nagashima, K., Mirro, J., Cho, E., Lockett, S., Rein, A.
(2004). Role of Murine Leukemia Virus Nucleocapsid Protein in Virus Assembly. J. Virol.
78: 12378-12385
[Abstract]
[Full Text]
-
Akahata, W., Ido, E., Hayami, M.
(2003). Mutational analysis of two zinc-finger motifs in the nucleocapsid protein of simian immunodeficiency virus mac239. J. Gen. Virol.
84: 1641-1648
[Abstract]
[Full Text]
-
Fu, W., Hu, W.-S.
(2002). Functional Replacement of Nucleocapsid Flanking Regions by Heterologous Counterparts with Divergent Primary Sequences: Effects of Chimeric Nucleocapsid on the Retroviral Replication Cycle. J. Virol.
77: 754-761
[Abstract]
[Full Text]
-
Guo, J., Wu, T., Kane, B. F., Johnson, D. G., Henderson, L. E., Gorelick, R. J., Levin, J. G.
(2002). Subtle Alterations of the Native Zinc Finger Structures Have Dramatic Effects on the Nucleic Acid Chaperone Activity of Human Immunodeficiency Virus Type 1 Nucleocapsid Protein. J. Virol.
76: 4370-4378
[Abstract]
[Full Text]